CymaBay Announces Participation at Cantor Fitzgerald Healthcare Conference on July 12th in New York
NEWARK, Calif., July 07, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today announced that management will …